A Study to Evaluate Absorption, Distribution and Elimination of Mirabegron After Oral Administration to Non-elderly Healthy Chinese Subjects

NCT01747564 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Plasma Concentration of Mirabegron

Interventions

DRUG: YM178 (mirabegron)

Sponsor

Astellas Pharma Inc